Does ALISERTIB Cause Malignant neoplasm progression? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Malignant neoplasm progression have been filed in association with ALISERTIB. This represents 11.9% of all adverse event reports for ALISERTIB.
10
Reports of Malignant neoplasm progression with ALISERTIB
11.9%
of all ALISERTIB reports
1
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ALISERTIB?
Of the 10 reports, 1 (10.0%) resulted in death.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALISERTIB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does ALISERTIB Cause?
Neutropenia (16)
Dehydration (12)
Hyponatraemia (10)
Toxicity to various agents (10)
Anaemia (9)
Leukopenia (9)
Lymphopenia (9)
Mucosal inflammation (9)
Febrile neutropenia (8)
Fatigue (7)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)